 UPCOMING EDUCATIONJoin ICHS for an interactive, case-based webinar where real-world scenarios set the stage for a dynamic discussion on the latest evidence and the outlook of Helicase Primase Inhibitors (HPIs). This session will reflect the evolution of the field with the future introduction of HPIs, the available clinical evidence, and how these therapies may be integrated into Dr. Roy Chemaly will facilitate a moderated discussion with the presenters to provide attendees with both the scientific rationale and the clinical context for incorporating HPIs into future management strategies for Refractory HSV in immunocompromised patients. During the webinar we will:
Free for ICHS members (log in first for this option.) Non-members: $25USD - includes a one year membership. MORE INFORMATION AND REGISTRATION Contact the ICHS team at admin@ichs.org if you need any assistance. |  ICHS MEMBERSHIPJoin ICHS with members across 58 countries and enhance patient care by actively engaging with a community of experts. ICHS members receive a reduced registration fee for educational events. New reduced $25 annual membership dues are now offered. For assistance with your membership, please contact us at admin@ichs.org. As a member of ICHS, you will gain access to a wealth of resources, networking opportunities, and exclusive benefits tailored to support your professional growth. ICHS members receive free webinar registrations and a reduced registration fee for educational events. New reduced $25 annual membership dues are now offered. For assistance with your membership, please contact us at admin@ichs.org. |  UPCOMING EDUCATION
In this webinar we will present a case-based approach to evaluating immunocompromised travelers returning from South America, the Middle East, and Asia, with syndromes such as fever, rash, skin lesions, etc, focusing on locally prevalent arbovirus infections, bacterial and parasitic infections. Participants will review region-specific and country-specific epidemiologic risks, differential diagnoses, practical approaches to diagnosis in non-endemic settings, treatment, and prevention. Emphasis will be placed on how clinical presentation, diagnosis, prevention, and management of these travel-related infections might differ in immunocompromised populations (SOT/HCT/B-cell depletion) compared with immunocompetent travelers. During the webinar we will aim to:
Free for ICHS members (log in first for this option.) Non-members: $25USD - includes a one year membership. More Information and RegistrationContact the ICHS team at admin@ichs.org if you need any assistance. |
|
ICHS 17th Biennial Symposium PHOTO ALBUM
View photos here
 | International Immunocompromised Host Societyadmin@ichs.org | +1 412-344-1414 |